Literature DB >> 1911764

Sequence specificity in triple-helix formation: experimental and theoretical studies of the effect of mismatches on triplex stability.

J L Mergny1, J S Sun, M Rougée, T Montenay-Garestier, F Barcelo, J Chomilier, C Hélène.   

Abstract

The specificity of a homopyrimidine oligonucleotide binding to a homopurine-homopyrimidine sequence on double-stranded DNA was investigated by both molecular modeling and thermal dissociation experiments. The presence of a single mismatched triplet at the center of the triplex was shown to destabilize the triple helix, leading to a lower melting temperature and a less favorable energy of interaction. A terminal mismatch was less destabilizing than a central mismatch. The extent of destabilization was shown to be dependent on the nature of the mismatch. Both single base-pair substitution and deletion in the duplex DNA target were investigated. When a homopurine stretch was interrupted by one thymine, guanine was the least destabilizing base on the third strand. However, G in the third strand did not discriminate between a C.G and an A.T base pair. If the stretch of purines was interrupted by a cytosine, the presence of pyrimidines (C or T) in the third strand yielded a less destabilizing effect than purines. This study shows that oligonucleotides forming triple helices can discriminate between duplex DNA sequences that differ by one base pair. It provides a basis for the choice of antigene oligonucleotide sequences targeted to selected sequences on duplex DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911764     DOI: 10.1021/bi00104a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  Triplex formation by oligonucleotides containing novel deoxycytidine derivatives.

Authors:  C Y Huang; G Bi; P S Miller
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

2.  Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

Authors:  C Shen; A Buck; G Mehrke; B Polat; H Gross; M Bachem; S Reske
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

3.  Elucidation of the sequence-specific third-strand recognition of four Watson-Crick base pairs in a pyrimidine triple-helix motif: T.AT, C.GC, T.CG, and G.TA.

Authors:  K Yoon; C A Hobbs; J Koch; M Sardaro; R Kutny; A L Weis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Molecular recognition via triplex formation of mixed purine/pyrimidine DNA sequences using oligoTRIPs.

Authors:  Jian-Sen Li; Fa-Xian Chen; Ronald Shikiya; Luis A Marky; Barry Gold
Journal:  J Am Chem Soc       Date:  2005-09-14       Impact factor: 15.419

Review 5.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

6.  Prediction of the stability of DNA triplexes.

Authors:  R W Roberts; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

7.  Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.

Authors:  R K Mishra; R Le Tinévez; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Proton exchange and local stability in a DNA triple helix containing a G.TA triad.

Authors:  L Jiang; I M Russu
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

9.  Effect of abasic linker substitution on triplex formation, Sp1 binding, and specificity in an oligonucleotide targeted to the human Ha-ras promoter.

Authors:  C Mayfield; D Miller
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

10.  Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine.

Authors:  C Giovannangéli; M Rougée; T Garestier; N T Thuong; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.